Fennec Announces Results of Annual Meeting

Fennec (NASDAQ:FENC)/b) reported voting results from its Annual General and Special Meeting held June 10, 2025.

Rhea-AI Summary

Fennec (NASDAQ:FENC)/b) reported voting results from its Annual General and Special Meeting held June 10, 2025. Shareholders elected five director nominees, each receiving at least 93.62% of votes cast. Investors also approved auditor appointment, executive compensation and amendments to the 2020 Equity Incentive Plan with strong majorities.

Positive

• All five director nominees received at least 93.62% of votes cast
• Auditor appointment approved with 99.64% shareholder support
• Executive compensation received 85.50% shareholder approval
• 2020 Equity Incentive Plan amendments backed by 91.27% of votes cast
• Equity plan amendments supported by 88.01% of disinterested shareholders

Negative

• None.

Argus Jun 11 session

+1.72% close to close Open Argus

Details

News Market Reaction – FENC

On Jun 11, the first trading day after this news, FENC closed 1.72% above the previous close.

Data tracked by StockTitan Argus for the Jun 11 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

06/10/2026 - 04:30 PM

RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.

Detailed results of the vote for the election of directors are set out below:

Name of Nominee	Votes For	% Votes For		Votes Withheld	% Votes Withheld
Dr. Khalid Islam	13,858,131	97.84	%	304,760	2.15	%
Mr. Chris A. Rallis	13,808,792	97.49	%	354,099	2.50	%
Mr. Marco Brughera	13,807,501	97.49	%	355,390	2.50	%
Dr. Jodi Cook	13,259,894	93.62	%	902,997	6.37	%
Mr. Jeff Hackman	13,495,309	95.28	%	667,582	4.71	%

Shareholders voted 99.64% in favor of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, 85.50% in favor of the compensation paid to the Company’s named executive officers, and 91.27% (88.01% after subtracting shares held by insiders eligible to participate in the Company’s 2020 Equity Incentive Plan) in favor of certain amendment to the Company’s 2020 Equity Incentive Plan.

The Company has relied on the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible interlisted issuers on a recognized exchange, such as Nasdaq, in the approval of the amendments to its 2020 Equity Incentive Plan.

For further information, please contact:

Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
Tel: 919-246-5299

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Fennec (NASDAQ:FENC) announce about its June 10, 2025 annual meeting results?

Fennec announced that all director nominees and key proposals passed at the June 10, 2025 annual meeting. According to Fennec, shareholders approved directors, auditors, executive compensation and amendments to the 2020 Equity Incentive Plan with strong majority support across all voting items.

How did Fennec (FENC) shareholders vote on director elections at the 2025 annual meeting?

Fennec shareholders elected all five nominated directors at the 2025 annual meeting. According to Fennec, support ranged from 93.62% of votes cast for Dr. Jodi Cook to 97.84% for Dr. Khalid Islam, with low levels of withheld votes across the slate.

What level of support did FENC shareholders give to auditor appointment at the 2025 meeting?

Shareholders showed very high support for Fennec’s auditor appointment at the 2025 meeting. According to Fennec, 99.64% of votes cast favored appointing Haskell & White LLP and authorizing directors to set auditor remuneration for the coming year.

How did Fennec (FENC) shareholders vote on executive compensation in June 2025?

Fennec shareholders approved executive compensation at the June 2025 meeting. According to Fennec, 85.50% of votes cast supported the compensation paid to the company’s named executive officers in the advisory say-on-pay vote held during the annual and special meeting.

Were Fennec’s 2020 Equity Incentive Plan amendments approved by FENC shareholders?

Yes, shareholders approved amendments to Fennec’s 2020 Equity Incentive Plan. According to Fennec, 91.27% of votes cast supported the amendments, or 88.01% after excluding insider-held shares eligible to participate in the plan from the disinterested shareholder calculation.

What TSX exemption did Fennec rely on for the 2020 Equity Incentive Plan amendments?

Fennec relied on a specific TSX exemption for its equity plan amendments. According to Fennec, the company used Section 602.1 of the TSX Company Manual, which allows certain interlisted issuers on exchanges like Nasdaq to bypass some TSX approval standards.